Julian Gangolli, a former Allergan Inc executive, has joined the board of directors of GW Pharmaceuticals Plc having earlier been appointed to the newly creation position of president, North America. He will help oversee the commercialisation of the company’s cannabinoid product for epilepsy.
Mr Gangolli was president of the North American pharmaceutical division of Allergan from 2004 until April 2015 where he was also a member of the executive committee. Prior to that, he was head of sales and marketing at Vivus Inc and worked at Syntex Pharmaceuticals Inc and Ortho-Cilag Pharmaceuticals Ltd.
GW Pharmaceuticals announced the appointment on 21 July 2015.
Copyright 2015 Evernow Publishing Ltd